[Expression and significance of urokinase-type plasminogen activator in medulloblastoma].
To detect the expression and evaluate the clinical significance of urokinase-type plasminogen activator (uPA) in medulloblastoma. LSAB (labelled streptavidin biotin method) immunohistochemical technique was applied for detecting the expression of uPA in 50 patients with medulloblastoma, and a follow-up survey with Cox regression analysis was made. The staining for uPA was localized on tumor cells and endothelial cells. Cox regression analysis showed that uPA was an independent prognostic factor affecting survival and it had a negative correlation with the prognosis. uPA appears to be an independent marker for predicting the prognosis of medulloblastoma.